Clinical Trial Update: Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating pulmonary suffusion to control minimal residual disease in patients with metastatic sarcoma or colorectal metastases is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Colorectal Cancer
• Soft Tissue Sarcoma

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Metastatic Bone Sarcoma, Metastatic Malignant Neoplasm in the Lung | Phase 1, Phase 2 | Status: RECRUITING